How can Europe improve its research preparedness and response capabilities in a post-pandemic🌍? Had the pleasure to discuss these and other challenges with Dr Claire Skentelbery Ab Osterhaus & Momir Radulovic #RiDaysEU LIVE #ResearchImpactEU #EUHealthResearch

Executive Director of JAZMP is a breath of fresh air in the EU regulator panorama. Serious as regulation must be, it doesn't shy away from digital innovation, regulatory flexibility and the importance of optimizing existing (often limited) resources. #AESGPregconf2021

Today there are many new therapies to treat rare or genetic diseases. But these often come with a high price tag. How can we ensure both #innovation and fair access? Find out more 👉 bit.ly/3HQrvpa 📅🕑13 January, 14:00 CET #OsloMedicinesInitiative

📽️Tune in tomorrow for our first webinar under the #OsloMedicinesInitiative, discussing with experts and practitioners how we can promote access to novel medicines. Register here 👉 bit.ly/3HQrvpa

We'll discuss with experts including Sarah Garner Natasha Azzopardi Muscat @Christinerdal Momir Radulovic Thomas Allvin Francesca Colombo @WardRommel @dimitrapanteli Helse- og omsorgsdep Other webinars from this series organised by WHO/Europe Helse- og omsorgsdep 👉 omi-euro.org/events/webinars

Join us next Tuesday 18 January at 14:00 CET to discuss how to advance #transparency of real #pharmaceutical costs A complex but very timely debate and we have an amazing lineup of speakers! Register here: bit.ly/34S0G5T

Do we always pay for breakthrough #innovation❓ Or do we overpay it❓ Momir Radulovic, Director of JAZMP, express some concerns about innovative #pharmaceutical products and the #transparency of their prices. What's your view on this? Let us know below 👇 #Affordability

#Affordability of medicines: Momir Radulovic, the Agency for Medicinal Products and medical devices, supports the revision of the #Transparency directive. Patients do too. Costs and price transparency help improve access to medicines through fair prices The European Public Health Alliance (EPHA) European Alliance Responsible R&D Affordable Meds

💬According to Momir Radulovic of JAZMP, member states & the #EU should attach conditionalities to their public funding in R&D both at the national & EU level to ensure that it is accounted for & that medicines resulting from it are available at a fair and affordable price

📺(Re)watch our webinar on how to advance transparency of R&D and other real pharmaceutical costs with: ▪️Ellen 't Hoen - @ellenthoen.bsky.social of Medicines Law&Policy ▪️Momir Radulovic of JAZMP ▪️Anne Hendrickx of @solidaris ▪️Harald Mische of EU One Health 🧐⤵️bit.ly/3tYHE8o

📢There's a sound rationale for increased #collaboration among 🇪🇺countries in the procurement of health technologies! 🎗️On #WorldCancerDay, read how to build strong collaboration to achieve #FairPrices4Meds👇 🔎bit.ly/3xZjBWK 🔗bit.ly/3ozs1B7

LUKA MAGIC OMG The announcers >>>>>>>>

In this session we reflect on the experience during the #COVID19 pandemic & #monkeypox outbreak, this session is focused on digging into the future of EU joint procurement for medicines & vaccines. 💊💉 'Medicines should be treated as a necessity and not a commodity.' Momir Radulovic

The overhaul of the #EUPharmaLegislation is the hottest topic in healthcare right now. We brought policy makers and regulators together to debate at #AESGP59AM. But will the proposed solutions in EU One Health proposal be enough to solve current problems? Let us know ur thoughts ⬇️

A wonderful panel addressing #EUPharmaLaw proposals on challenges, such as: 📦#shortages preparation 🦠#AMR mitigation measures 💻#digitalisation + #PatientInformation 🍀#environment #sustainability Olga Solomon Momir Radulovic EU One Health EU Medicines Agency

#EUPharmaLaw will be delivered as a Directive 🇪🇺 leaving some leeway for Member States to ⚖️adapt to national reality and 📃apply non-conflicting requirements in the several aspects of the legislation. National #Medicines #Regulators are paying attention! #AESGP59AM Momir Radulovic

Momentum for reflection and future proofing!

Breaking down silos, bringing CGT into mainstream together moderated by Jane Kinghorn, our partner at CTGCT #econcellgenetherapysummit

🗣️Emer Cooke, Executive Director of the European Medicines Agency EU Medicines Agency was the keynote speaker at our joint event on shortages with European Doctors addressing the different challenges related to #medicineshortages

Momir Radulović, Executive Director of the Agency for medicinal products and medical devices of the Republic of Slovenia JAZMP provided a regulatory view in the panel debate on medicine shortages at the PGEU-European Doctors joint event in Amsterdam